Home » Topics » Regulatory, BioWorld Science

Regulatory, BioWorld Science
RSS

IL-2 treatment dramatically effective in AIDS patients

Nov. 8, 1996

MiKasome cleared for clinical trials in HIV-positive patients

Nov. 8, 1996

New, more convenient testosterone transdermal patch submitted for approval

Nov. 1, 1996

Pfizer 5-HT reuptake inhibitor approved in U.S. for new indication

Nov. 1, 1996

Cefzil approved for new indication in U.S.

Nov. 1, 1996

Additional clinical data support the potential of DepoCyt in neoplastic meningitis

Oct. 25, 1996

Sulfasalazine approved for rheumatoid arthritis

Oct. 25, 1996

Expanded indications for Abelcet

Oct. 25, 1996

Cholestyramine treatment of peri-anal irritation in an infant

Oct. 25, 1996

Anesta's Actiq on schedule for launch

Oct. 25, 1996

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...